Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Aspen’s share price plummeted by 30% after it warned shareholders that its earnings could significantly decline due to a ...

They're not just leaders of their industry. Their underlying businesses are also on the verge of enormous growth.

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...

The biotech industry has been under pressure due to the global uncertainty caused by the tariff war. Though pharmaceuticals ...

Emerging markets equities demonstrated resilience in Q1 against a backdrop of heightened geopolitical uncertainty and ...

Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks ...

WASHINGTON (Reuters) -Talks continue between the U.S. and China on tackling the fentanyl epidemic amid the bitter trade war ...

"European price controls and austerity measures reduce the attractiveness of its markets," Novartis CEO Vas Narasimhan and ...